NSEDCP
NJ State Employees Deferred Compensation Plan Portfolio holdings
AUM
$846M
1-Year Return
19.82%
This Quarter Return
+16.04%
1 Year Return
+19.82%
3 Year Return
+98.28%
5 Year Return
+197.72%
10 Year Return
+449.68%
AUM
$550M
AUM Growth
+$69.7M
(+15%)
Cap. Flow
-$1.01M
Cap. Flow
% of AUM
-0.18%
Top 10 Holdings %
Top 10 Hldgs %
19.3%
Holding
562
New
46
Increased
72
Reduced
103
Closed
24
Top Buys
| 1 |
S
Sprint Corporation
S
|
$2.26M |
| 2 |
CELG
Celgene Corp
CELG
|
$1.13M |
| 3 |
Abbott
ABT
|
$1.12M |
| 4 |
AGN
Allergan plc
AGN
|
$732K |
| 5 |
Axon Enterprise
AXON
|
$707K |
Top Sells
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
$1.97M |
| 2 |
Pfizer
PFE
|
$1.61M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$1.46M |
| 4 |
Zoetis
ZTS
|
$1.11M |
| 5 |
Merck
MRK
|
$1.08M |
Sector Composition
| 1 | Technology | 19.66% |
| 2 | Financials | 15.47% |
| 3 | Industrials | 12.72% |
| 4 | Healthcare | 12.28% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Lumentum
LITE
$10.4B
| $592K | 0.11% |
10,475
-3,000
| -22% | -$170K |
|
202
Acadia Healthcare
ACHC
$2.19B
| $586K | 0.11% |
20,000
| – | – |
|
203
McKesson
MCK
$85.5B
| $585K | 0.11% |
5,000
-3,000
| -38% | -$351K |
|
204
HP
HPQ
$27.4B
| $583K | 0.11% |
30,000
| – | – |
|
205
EchoStar
SATS
$19.3B
| $583K | 0.11% |
19,744
| – | – |
|
|
NAV
206
DELISTED
Navistar International
NAV
| $581K | 0.11% |
18,000
-3,000
| -14% | -$96.8K |
|
207
LivePerson
LPSN
$89.9M
| $580K | 0.11% |
20,000
| – | – |
|
208
Pacific Biosciences
PACB
$381M
| $578K | 0.11% |
80,000
+30,000
| +60% | +$217K |
|
209
Edwards Lifesciences
EW
$47.5B
| $574K | 0.1% |
+9,000
| New | +$574K |
|
210
Elevance Health
ELV
$70.6B
| $574K | 0.1% |
+2,000
| New | +$574K |
|
|
PYX
211
DELISTED
Pyxus International, Inc.
PYX
| $573K | 0.1% |
24,000
-3,000
| -11% | -$71.6K |
|
212
Chegg
CHGG
$185M
| $572K | 0.1% |
15,000
-3,000
| -17% | -$114K |
|
213
Koppers
KOP
$569M
| $572K | 0.1% |
22,000
-14,000
| -39% | -$364K |
|
214
Amgen
AMGN
$153B
| $570K | 0.1% |
+3,000
| New | +$570K |
|
|
ISCA
215
DELISTED
International Speedway Corp
ISCA
| $567K | 0.1% |
13,000
+3,000
| +30% | +$131K |
|
216
TD Synnex
SNX
$12.3B
| $567K | 0.1% |
11,894
| – | – |
|
|
JBTM
217
JBT Marel Corporation
JBTM
$7.35B
| $566K | 0.1% |
6,160
-3,000
| -33% | -$276K |
|
218
Acadia Pharmaceuticals
ACAD
$4.26B
| $564K | 0.1% |
21,000
| – | – |
|
|
WW
219
DELISTED
WW International
WW
| $564K | 0.1% |
28,000
+17,000
| +155% | +$342K |
|
220
Agilent Technologies
A
$36.5B
| $563K | 0.1% |
+7,000
| New | +$563K |
|
|
BFYT
221
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $563K | 0.1% |
21,000
+1,000
| +5% | +$26.8K |
|
222
NETSCOUT
NTCT
$1.79B
| $561K | 0.1% |
19,977
| – | – |
|
223
Aecom
ACM
$16.8B
| $560K | 0.1% |
18,879
| – | – |
|
|
CADE
224
DELISTED
Cadence Bancorporation
CADE
| $557K | 0.1% |
30,000
+6,000
| +25% | +$111K |
|
225
Griffon
GFF
$3.79B
| $554K | 0.1% |
30,000
| – | – |
|